No black box warning on record for Paricalcitol

As of the latest FDA labeling reviewed, Paricalcitol (PARICALCITOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Paricalcitol medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Excessive administration of vitamin D compounds. including Paricalcitol Capsules, can cause over suppression of PTH, hypercalcemia, hypercalciuria, hyperphosphatemia, and adynamic bone disease. 5.1 Hypercalcemia Progressive hypercalcemia due to overdosage of vitamin D and its metabolites may be so severe as to require emergency attention [ see Overdosage (10) ] . Acute h

No black box warning on record for Paricalcitol

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Excessive administration of vitamin D compounds. including Paricalcitol Capsules, can cause over suppression of PTH, hypercalcemia, hypercalciuria, hyperphosphatemia, and adynamic bone disease. 5.1 Hypercalcemia Progressive hypercalcemia due to overdosage of vitamin D and its metabolites may be so severe as to require emergency attention [ see Overdosage (10) ] . Acute h

Paricalcitol Black Box Warning

No black box warning on record for Paricalcitol

Other warnings & precautions

Paricalcitol Black Box Warning

No black box warning on record for Paricalcitol

Other warnings & precautions